US Broker Ratings

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Medtronic plc (MDT) Stock Analysis: Exploring a 11.50% Potential Upside in the Healthcare Sector

Medtronic plc (MDT) stands as a prominent player in the healthcare sector, renowned for its innovative medical devices that have a global footprint. Headquartered in Galway,..

BioNTech SE (BNTX): Investor Outlook and Growth Potential with a 28% Upside

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has garnered significant attention from investors, especially in light of its role in developing immunotherapies..

Agilent Technologies, Inc. (A) Investor Outlook: Navigating a 2.42% Potential Upside Amid Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A), a leader in the diagnostics and research industry, continues to capture investor attention with its solid market presence and promising growth..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 16.54% Potential Upside Amid Solid Revenue Growth

Becton, Dickinson and Company (NYSE: BDX), a venerable figure in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a..

DexCom, Inc. (DXCM) Investor Outlook: Exploring a 50.81% Upside Potential in the Innovative CGM Market

DexCom, Inc. (DXCM), a leading player in the healthcare sector, specializes in medical devices with a primary focus on continuous glucose monitoring (CGM) systems. As the..

Boston Scientific Corporation (BSX) Investor Outlook: Analyzing the 25% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, particularly in the medical devices industry, presents an attractive prospect for investors with a..

Eli Lilly and Company (LLY) Stock Report: Analyzing a Healthcare Giant’s Impressive Revenue Growth and Analyst Confidence

Eli Lilly and Company, listed under the symbol LLY, stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in..

Cardinal Health, Inc. (CAH) Stock Report: Analyzing Growth Potential and Analyst Consensus

Cardinal Health, Inc. (NYSE: CAH) is a prominent player in the healthcare sector, specializing in medical distribution. With a market cap of $45.33 billion, the company..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the 4.43% Potential Upside and Strong Dividend Yield

As a titan in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) is a stalwart in the drug manufacturing industry, boasting a robust market capitalization of $160.66..

Novo Nordisk (NVO) Stock Analysis: A Healthcare Giant with 21% Potential Upside

Novo Nordisk A/S (NVO), a behemoth in the healthcare sector, presents an appealing investment opportunity for those keen on the pharmaceutical industry. Headquartered in Bagsvaerd, Denmark,..

Danaher Corporation (DHR) Stock Analysis: Unlocking an 18% Upside in the Diagnostics & Research Sector

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, continues to capture investor interest with its robust..

HCA Healthcare, Inc. (HCA) Investor Outlook: Revenue Growth and Analyst Ratings Signal Promising Prospects

HCA Healthcare, Inc. (NYSE: HCA), a leading player in the healthcare sector, has captured investor attention with its robust market presence and promising financial metrics. With..

Pfizer, Inc. (PFE) Stock Analysis: A Strong Dividend Yield and Promising Upside

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, stands out in the drug manufacturing industry with its robust pipeline of biopharmaceutical products. As an..

Elevance Health, Inc. (ELV) Stock Analysis: Unlocking a 22.69% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a prominent player in the Healthcare Plans industry, is capturing attention with a potential upside of 22.69%. With a market capitalization..

AstraZeneca PLC (AZN) Stock Analysis: Exploring the 13% Upside Potential Amid Strong Buy Ratings

AstraZeneca PLC, trading under the stock symbol AZN, stands as a formidable player in the healthcare sector, specifically within the drug manufacturers’ industry. With its headquarters..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 20% Potential Upside with Robust Revenue Growth

In the dynamic world of healthcare, Stryker Corporation (NYSE: SYK) has long stood as a formidable player, particularly within the medical devices industry. With a robust..

AbbVie Inc. (ABBV) Stock Analysis: High Dividend Yield and Promising Upside Potential

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, is at the forefront of the pharmaceutical industry with its robust portfolio of medicines and therapies..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a Potential 54% Upside Amidst Challenges

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors willing to navigate its..

Autolus Therapeutics (AUTL) Stock Analysis: Exploring a 537% Potential Upside in Biotech Innovation

Autolus Therapeutics plc (NASDAQ: AUTL) is capturing the attention of investors with its impressive potential upside of 537.23%, a figure that stands out in the competitive..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds